Sorafenib Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.3 Hormones and antihormones Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Sorafenib Manufacturers of Sorafenib Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Sorafenib's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 400 to 800 mg600 (600)As recommended.POat least 1 hour before or 2 hours after a meal Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Sorafenib is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Sorafenib is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Sorafenib Back to top Manufacturers of Sorafenib in Pakistan Bayer Back to top Previous Drug Generic - Next Drug Generic